Who owns ABVC BIOPHARMA INC?
- Ticker: ABVC
- CUSIP Number: 00091f304
Tip: Access positions for across all investors
Analyze quarterly positions in Abvc Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abvc Biopharma stock
Who bought or sold ABVC BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 375k | $592k | 97% | Jun 2026 |
|
| Geode Capital Management | 228k | $360k | 3% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 97k | $154k | 0% | Jun 2026 |
|
| Citadel Advisors | 84k | $132k | 100% | Jun 2026 |
|
| State Street Corporation | 73k | $71k | 0% | Mar 2026 |
|
| BlackRock | 56k | $89k | 0% | Jun 2026 |
|
| Northern Trust | 49k | $77k | 52% | Jun 2026 |
|
| XTX Topco | 48k | $76k | 100% | Jun 2026 |
|
| PanAgora Asset Management | 37k | $58k | 100% | Jun 2026 |
|
| UBS Group | 34k | $54k | 1827% | Jun 2026 |
|
| Jane Street | 20k | $32k | 87% | Jun 2026 |
|
| LifeSteps Financial | 300.00 | $474.000000 | 100% | Jun 2026 |
|
| Royal Bank of Canada | 17.00 | $0 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 6.00 | $9.000000 | 100% | Jun 2026 |
|
Who sold out of Abvc Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Mar 2026 | 95k | $92k |
| Two Sigma Securities | Mar 2026 | 21k | $20k |
| Dimensional Fund Advisors | Mar 2026 | 12k | $12k |
| Squarepoint Ops | Mar 2026 | 11k | $10k |
| Tower Research Capital | Mar 2026 | 5.4k | $5.3k |
| Morgan Stanley | Dec 2025 | 5.2k | $10k |